Inventurus Knowledge Solutions
add_icon

Inventurus Knowledge Solutions

1,395.00
+25.70
(1.88%)
Market Cap
23,934.46 Cr
PE Ratio
35.41
Volume
35,253.00
Day High - Low
1,395.00 - 1,355.00
52W High-Low
1,876.00 - 1,236.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
23,934.46 Cr
EPS
29.20
PE Ratio
35.41
PB Ratio
10.48
Book Value
130.54
EBITDA
808.70
Dividend Yield
0.00 %
Return on Equity
27.16
Debt to Equity
0.74
Analyst Rating and Forecast
- By Refinitiv from8 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+87.50 %
+87.50 %
Hold
Hold+12.50 %
+12.50 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Inventurus Knowledge Solutions completed second tranche investment of USD 20,990,505 in wholly owned subsidiary IKS Inc, acquiring 32,635 shares and concluding the approved investment plan.
positive
Inventurus Knowledge Solutions' IKS Health announces strategic acquihire of AI-led company ThinkDTM to expand patient access solutions and strengthen AI capabilities in healthcare operations.
positive
IKS Health and Certilytics announce expanded strategic collaboration to bridge payer-provider gap using agentic AI and human oversight for prior authorization, member engagement, and price transparency.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,375.40
#1 35,778.61
28.18
#1 10,880.10
10.41
#1 1,264
-5.13
50.93
1,395.00
#2 23,934.46
#4 35.41
#6 2,703.00
#2 45.49
#5 486
#3 41.33
47.47
544.15
22,091.36
41.51
5,292.60
1.14
677
-96.09
46.39
42.62
19,951.82
23.44
5,626.20
17.67
539
23.42
54.52
1,413.80
19,900.28
45.54
2,360.10
24.22
382
19.06
51.49
817.80
9,087.72
#1 15.48
7,457.00
3.38
648
-23.88
39.47
474.00
8,081.26
39.33
5,971.90
-5.22
205
-11.41
43.65
1,648.40
7,008.57
68.30
1,051.60
8.33
75
87.16
67.96
316.25
6,841.72
254.84
1,223.30
29.83
-69
#1 291.14
28.26
2,373.40
4,878.52
-563.80
203.40
#1 111.65
48
-149.14
50.63

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
45.49 %
Net Income Growth
31.20 %
Cash Flow Change
51.54 %
ROE
-15.13 %
ROCE
22.60 %
EBITDA Margin (Avg.)
-0.80 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
573
635
644
648
684
727
743
785
821
Expenses
405
494
467
454
476
498
502
511
536
EBITDA
168
140
177
194
208
229
241
274
285
Operating Profit %
29 %
20 %
27 %
29 %
28 %
31 %
32 %
35 %
34 %
Depreciation
19
27
28
28
28
28
28
30
32
Interest
26
32
26
22
21
21
18
16
23
Profit Before Tax
124
81
122
144
160
180
195
228
229
Tax
22
17
27
31
31
32
43
47
46
Net Profit
102
64
96
113
130
148
152
181
183
EPS in ₹
6.14
3.84
5.75
6.80
7.80
8.88
9.07
10.81
10.96

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
434
586
788
988
3,028
3,052
Fixed Assets
36
87
76
59
1,833
1,790
Current Assets
233
345
461
698
898
784
Capital Work in Progress
0
0
0
0
3
13
Investments
1
14
16
32
195
114
Other Assets
397
485
696
898
997
1,135
Total Equity & Liabilities
434
586
788
988
3,028
3,052
Current Liabilities
81
59
83
115
790
521
Non Current Liabilities
70
70
58
45
1,080
741
Total Equity
283
457
647
829
1,158
1,790
Reserve & Surplus
274
448
630
812
1,140
1,773
Share Capital
8
8
17
17
17
17

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
43
-28
92
-22
-147
170
Investing Activities
-79
-167
-82
-158
-1,137
241
Operating Activities
163
175
233
288
210
318
Financing Activities
-41
-37
-59
-152
780
-390

Share Holding

% Holding
Aug 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
69.73 %
63.72 %
63.72 %
63.72 %
63.72 %
63.72 %
FIIs
0.00 %
5.48 %
5.39 %
6.50 %
7.02 %
7.56 %
DIIs
0.00 %
4.45 %
4.03 %
4.33 %
4.89 %
6.06 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
10.25 %
10.93 %
10.81 %
10.83 %
10.33 %
Others
30.27 %
16.10 %
15.93 %
14.64 %
13.53 %
12.33 %
No of Share Holders
110
109
57,714
59,218
57,577
60,788

Announcements

Announcement under Regulation 30 (LODR)-Updates on Acquisition4 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release6 days ago
Announcement under Regulation 30 (LODR)-Updates on Acquisition10 days ago
Closure of Trading Window10 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 24, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 18, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMar 13, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Order Received From Office Of The Development Commissioner SEEPZ-Special Economic Zone Mumbai Ministry Of Commerce & Industry Government Of India.Mar 12, 2026
Grant Of Employee Stock Options Under Employee Stock Option Plan 2022Mar 05, 2026
Grant Of Employee Stock Options Under Employee Stock Option Plan 2022Feb 24, 2026
Grant Of Employees Stock Options Under Employee Stock Option Plan 2022.Feb 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 19, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 04, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 04, 2026
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.Feb 04, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On February 4 2026 - Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.Feb 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 03, 2026
Grant Of Employees Stock Options Under Employee Stock Option Plan 2022.Jan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 27, 2026
Board Meeting Intimation for The Meeting To Be Held On February 04 2026.Jan 27, 2026
Grant Of Employees Stock Options Under Employee Stock Option Plan 2022.Jan 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 07, 2026
Closure of Trading WindowDec 26, 2025
Grant Of Employees Stock Options Under Employee Stock Option Plan 2022.Dec 24, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 31, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementOct 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 30, 2025
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025.Oct 30, 2025
Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI LODR Regulations - Outcome Of The Board Meeting Held On October 30 2025 - Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended SepteOct 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 28, 2025
Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations) - Issuance Of Corporate Guarantee.Oct 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 17, 2025
Announcement under Regulation 30 (LODR)-AcquisitionOct 16, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 16, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations)Oct 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Axis Services Opportunities Fund Direct-Growth
0.00%
-193648
-1.59%
-1.74%
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
-45000
-1.10%
-1.14%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-6612
-0.35%
-0.40%
Bandhan Healthcare Fund Direct-Growth
0.00%
-5000
-0.23%
-0.28%
WhiteOak Capital Equity Savings Fund Direct-Growth
0.00%
-913
-0.05%
-0.06%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-238
-0.35%
-0.39%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-134
-0.03%
-0.04%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.00%
-86
-0.12%
-0.13%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
-27
-0.03%
-0.04%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.03%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.00%
0
0.00%
-0.16%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.03%
Baroda BNP Paribas Focused Fund Direct-Growth
0.00%
0
0.00%
-0.97%
Axis Small Cap Fund Direct-Growth
0.00%
0
0.00%
-0.45%
Baroda BNP Paribas Midcap Fund Direct-Growth
0.00%
0
0.00%
-0.41%
Baroda BNP Paribas Small Cap Fund Direct-Growth
0.00%
0
0.00%
-1.07%
Axis Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
-0.03%
Angel One Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.03%
Edelweiss Aggressive Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.35%
Edelweiss Recently Listed IPO Fund Direct-Growth
0.00%
0
0.00%
-1.56%
Edelweiss Small Cap Fund Direct-Growth
0.00%
0
0.00%
-0.84%
Groww Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.35%
Groww Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.03%
HDFC BSE 500 Index Fund Direct-Growth
0.00%
0
0.00%
-0.03%

Technical Indicators

RSI(14)
Neutral
47.47
ATR(14)
Volatile
56.53
STOCH(9,6)
Neutral
68.02
STOCH RSI(14)
Overbought
93.11
MACD(12,26)
Bullish
13.73
ADX(14)
Strong Trend
28.51
UO(9)
Bearish
53.26
ROC(12)
Uptrend And Accelerating
2.91
WillR(14)
Overbought
-16.17